Alvotech
Price & Volume
Stats
See more52W Range | $7.35-$13.70 |
Market Cap | $2.6B |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $562.4M |
Revenue Growth (YoY) | -12.8% |
Gross Profit (12 Mos) | $303M |
Diluted EPS | $0.23 |
News
See moreYahoo Finance • 5 days ago
Sector Update: Health Care Stocks Advance Tuesday Afternoon
Yahoo Finance • 6 days ago
European Medicines Agency Recommends Marketing Authorization of AVT03, Alvotech’s Proposed Biosimilar to Prolia® and Xgeva®
About
CEO | Mr. Robert Wessman |
Address | 9, Rue de Bitbourg, Luxembourg, Luxembourg, 1273 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 1,012 |
